Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Dumb Questions

Dumb Questions

posted on Nov 04, 2007 07:54PM

If settlement(s) is(are) really in the offing, in this scenario, is it pretty much a certainty that ALL of the remaining defendants are on board, or could one of them break off last minute and continue the fight?

Secondly, if a settlement is reached, I assume that would mean settlement with each defendant separately. Is that a correct assumption? If so, I'm sure each of the defendants would have a different level of infringment and would have different settlement numbers, correct?

Based on former defendant Fujitsu's settlement/license of $33M approx., I'd have to assume that these remaining defendants remained because they had larger exposure, so it seems safe to say that we could expect settlement figures with each company of at least $35M to $50M on the low end. Would most here agree?

If these are correct assumptions, from a market perception standpoint, I would think an announcement of a $150M plus joint settlement would have more impact than say the announcement of 3 separate $50M settlements. From a disclosure standpoint, I'm wondering if a combined value amount would allow PTSC/TPL to work around the non-disclosure issues, by not specifying who paid what, and by combining the settlement amount, forcing this to be considered a material event that would allow/require concurrent disclosure of the amount.

Thoughts?

Share
New Message
Please login to post a reply